| Metric | H1 FY27 | H1 FY26 | H2 FY26 |
|---|---|---|---|
| Revenue from operations | 22.6 | 0.0 | 24.3 |
| Other income | 2.0 | 0.0 | 1.5 |
| Total income | 24.6 | 0.0 | 25.8 |
| Profit before exceptional items & tax | 5.2 | 0.0 | 10.1 |
| Profit before tax | 5.2 | 0.0 | 10.1 |
| Net profit | 3.7 | 0.0 | 7.5 |
| Operating margin | 21.1% | 0.0% | 39.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -50.70% |
|---|---|
| Revenue, year on year | -7.00% |
| Operating profit, year on year | -62.80% |
BSE results filing, BSE: 544353. Figures extracted from the filing.
Amwill Health Care Ltd: key numbers
- Share price
- ₹43.00
- Market cap
- ₹86.02 Cr
- Revenue (annual)
- ₹45.49 Cr
- Net profit (annual)
- ₹11.42 Cr
- P/E (TTM)
- 7.5×Sector 46.5×
- Promoter holding
- 70.65%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amwill Health Care Ltd
All →Amwill Health Care Dividend
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care Board Meeting Date
Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.
Amwill Health Care Other Announcement
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care Regulatory Approval
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Amwill Health Care Acquisition Worth ₹3 Cr
Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
- Value
- ₹3.00 Cr
- Execution
- Ensuing month(s)
Amwill Health Care Management Change
Amwill Health Care Ltd re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for a five-year term, effective January 27, 2027.
- Execution
- 5 years